MARKET

PAVMW

PAVMW

PAVMED
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.250
-0.168
-3.80%
Closed 16:00 09/24 EDT
OPEN
4.200
PREV CLOSE
4.418
HIGH
4.400
LOW
4.080
VOLUME
7.61K
TURNOVER
--
52 WEEK HIGH
6.94
52 WEEK LOW
0.3600
MARKET CAP
--
P/E (TTM)
-7.7287
1D
5D
1M
3M
1Y
5Y
PAVmed's Subsidiary, Lucid Diagnostics Files For $58M IPO
Lucid Diagnostic, a maker of diagnostic tests for esophageal precancer and cancer, filed to raise up to $58 million in an IPO. In its Form S-1 filed with SEC, the New York-based company said it intends to list on NASDAQ under the ticker symbol LUCD. Lucid ...
Benzinga · 3d ago
BRIEF-PAVmed Says Subsidiary Lucid Diagnostics Filed Registration Statement For Proposed Initial Public Offering
reuters.com · 3d ago
PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering
NEW YORK, September 23, 2021--PAVmed subsidiary, Lucid Diagnostics, files registration statement for proposed initial public offering.
Business Wire · 3d ago
BRIEF-Lucid Diagnostics Files For IPO
reuters.com · 4d ago
PAVmed Subsidiary Veris Health Joins Microsoft for Startups Global Program and Engages Loka as Software Development Partner
NEW YORK, September 21, 2021--PAVmed subsidiary Veris Health joins Microsoft for startups global program and engages Loka as software development partner.
Business Wire · 5d ago
PAVmed to Participate in September Investor and MedTech Conferences
NEW YORK, September 07, 2021--PAVmed to participate in September investor and MedTech conferences.
Business Wire · 09/07 14:04
BRIEF-Pavmed Q2 Earnings Per Share Estimate $-0.10 -- Refinitiv Ibes Data
reuters.com · 08/12 22:35
PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results
NEW YORK, August 12, 2021--PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results. Conference call to be held today at 4:30 PM EDT.
Business Wire · 08/12 20:14
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PAVMW. Analyze the recent business situations of PAVMED through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.19%
Healthcare Equipment & Supplies
-0.42%
Key Executives
Chairman/Chief Executive Officer/Director
Lishan Aklog
President/Chief Financial Officer/Secretary
Dennis Mcgrath
Vice Chairman/Independent Director
Michael Glennon
Other
Brian DeGuzman
Director
Tim Baxter
Director
Debra White
Independent Director
James Cox
Independent Director
Ronald Sparks
Independent Director
David Weild
No Data
About PAVMW
PAVmed Inc. is a multi-product, commercial-stage technology medical device company. The Company has four operating divisions. GI Health division includes EsoGuard, EsoCheck and EsoCure. EsoGuard and EsoCheck have been developed to provide non-invasive, patient-friendly screening test for the early detection of adenocarcinoma of the esophagus (EAC) and Barrett's Esophagus (BE), including dysplasia and related pre-cursors to EAC in patients with chronic gastroesophageal reflux (GERD). EsoCure is in development as an Esophageal Ablation Device with the intent to allow a clinician to treat dysplastic BE before it can progress to EAC. Minimally Invasive Interventions division offers CarpX, a minimally invasive surgical device for carpal tunnel syndrome. Infusion Therapy division includes PortIO, which is an implantable, intraosseous vascular access device, and NextFlo, which is a disposable, infusion platform technology that includes intravenous infusion sets and disposable infusion pumps.

Webull offers kinds of PAVmed Inc stock information, including NASDAQ:PAVMW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAVMW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PAVMW stock methods without spending real money on the virtual paper trading platform.